Search results
Results from the WOW.Com Content Network
Ansoff pointed out that a diversification strategy stands apart from the other three strategies. Whereas, the first three strategies are usually pursued with the same technical, financial, and merchandising resources used for the original product line, the diversification usually requires a company to acquire new skills and knowledge in product development as well as new insights into market ...
An asset management company is an asset management / investment management company/firm that invests the pooled funds of retail investors in securities in line with the stated investment objectives. For a fee, the company/firm provides more diversification , liquidity , and professional management consulting service than is normally available ...
These high-quality investment funds offer a combination of exposure to today's hottest growth trends and diversification across companies of all sizes. 3 Growth ETFs to Buy With $2,000 and Hold ...
Non-incremental diversification is a strategy followed by conglomerates, where the individual business lines have little to do with one another, yet the company is attaining diversification from exogenous risk factors to stabilize and provide opportunity for active management of diverse resources.
3. Diversification is important. Cuban’s portfolio stretches far beyond the companies he selected on Shark Tank. His company has stakes in various firms, ranging from affordable generic drug ...
While the volatility of a single stock can lead to big winnings if the company takes off, your portfolio can suffer just as easily if that firm has a bad day. Diversification can help you smooth ...
A conglomerate is a combination of multiple business entities operating in entirely different industries under one corporate group, usually involving a parent company and many subsidiaries. Conglomerates are typically large and multinational corporations that manage diverse business operations across various sectors.
The index includes companies in pharmaceuticals, equipment and supplies, health-care providers and biotechnology, among others. 5-year returns (annualized): 12.4 percent Expense ratio: 0.09 percent